Dalid, Nelson G.

HRN: 24-54-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
CEFTAZIDIME 1GM (VIAL)
03/26/2026
04/01/2026
IV
1g
Q8h
CAP-Mr
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaMultiple Infections (tick All Sites)    Compliance to guidelines: